Latest Diabetic foot Stories
ADDISON, Texas, Nov. 10, 2010 /PRNewswire/ -- ULURU Inc.
In Conjunction with American Diabetes Month, November 2010 ROSEMONT, Ill., Oct. 25 /PRNewswire-USNewswire/ -- The statistics surrounding diabetes and diabetic related health issues are staggering.
ADDISON, Texas, Sept. 30 /PRNewswire/ -- ULURU Inc.
CANTON, Mass., Sept. 28 /PRNewswire/ -- Organogenesis, Inc. announced that its ApligrafÂ® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA) of the Kingdom of Saudi Arabia.
FORT WORTH, Texas, Aug. 18 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc.
People suffering from diabetes-related foot ulcers show different rates of healing according to the way they cope and their psychological state of mind.
ASHBURN, Va., July 13 /PRNewswire/ -- Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S.
Study indicates that molecular imaging can help diagnose and determine treatment for a range of foot ailments common in diabetic patients.
ZUG, Switzerland and CANTON, Mass., May 26 /PRNewswire/ -- Organogenesis Switzerland GmbH will sponsor a symposium on ApligrafÂ®, a bilayered living cellular construct for the treatment of chronic wounds and soft tissue repair, at the upcoming European Wound Management Association (EWMA) conference.
LOMBARD, Ill., April 26 /PRNewswire/ -- With over ten million diabetics in the U.S. alone and approximately 150,000 amputations performed yearly, inventor and American board-certified prosthetist John E.